These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 16382473)

  • 1. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Lin HC; Huang YH; Wu JC; Chiang JH; Lee PC; Lee SD
    Cancer; 2006 Jul; 107(1):141-8. PubMed ID: 16708358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P; Desai N; Alexander J; Singh DP; Sawant P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
    Huo TI; Lin HC; Hsia CY; Wu JC; Lee PC; Chi CW; Lee SD
    Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do chronic liver disease scoring systems predict outcomes in trauma patients with liver disease? A comparison of MELD and CTP.
    Seamon MJ; Franco MJ; Stawicki SP; Smith BP; Kulp H; Goldberg AJ; Santora TA; Gaughan JP
    J Trauma; 2010 Sep; 69(3):568-73. PubMed ID: 20838128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
    Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
    Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS; Palmer DE; Hoffman M; Longo W; Solomon H; Di Bisceglie AM
    Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Huang YH; Lin HC; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
    Am J Gastroenterol; 2006 May; 101(5):975-82. PubMed ID: 16573785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL; Chim AM; Lau JT; Hui AY; Wong VW; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.